
<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <title>ROCLING 2023 Shared Task</title>

    
    <!-- 匯入bootstrap -->
    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous">
    <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js" integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js" integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM" crossorigin="anonymous"></script>
  
    <!-- 匯入jQuery -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>

    <!-- Latest compiled and minified CSS -->
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
    <!-- Optional theme -->
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap-theme.min.css" integrity="sha384-rHyoN1iRsVXV4nD0JutlnGaslCJuC7uwjduW9SVrLvRYooPp2bWYgmgJQIXwl/Sp" crossorigin="anonymous">
    <!-- Latest compiled and minified JavaScript -->
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>


    <!-- 插入方程式 -->
    <script async src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script async id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

    <link rel="stylesheet" href="main.css">
    <meta name="viewport" content="width=device-width, initial-scale=1">
</head>

<body>

<!-- ============================================================================ -->


    <div>
        <nav class="nav navbar-default navbar-fixed-top topflex" id="topdiv">

            <div class="navbar-header" id="navheader">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#collapsingNavbarMd">
                    <span class="sr-only"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>

            <div class="collapse navbar-collapse navbar-collapse-center" id="collapsingNavbarMd">
                <ul class="nav navbar-nav navbar-center" >

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#intro">Background</a></li>

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#task">Task Description</a></li>

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#registration">Data</a></li>

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#key_note">Evaluation</a></li>

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#key_note">Results</a></li>
                    
                    <li class="single"><a href="javascript:;" class="navItems" navTo="#special">Important Date</a></li>

                    <li class="single"><a href="javascript:;" class="navItems" navTo="#special">Baseline System</a></li>
                    
                    <li class="single"><a href="javascript:;" class="navItems" navTo="#ref">References</a></li>

                </ul>
            </div>
        </nav>
    </div>
   

    <!-- ============================================================================ -->

    <div class="welcome">
        <div class="wrap">
            <div class="item text">
                <h1><span style="color: #2D82B7;">ROCLING 2023 Shared Task 1</span><br>
                    MultiNER-Health Chinese Multi-genre Named Entity Recognition in the Healthcare Domain</h1>
                <div class="session">
                    <h2>
                        Organizers
                    </h2>
                    <div class="people">
                        <div class="author">
                            <p>
                                <strong>李龍豪 Lung-Hao Lee、林孜彌 Tzu-Mi Lin、陳昭沂 Chao-Yi Chen</strong><br>
                                國立中央大學 電機工程學系<br>
                                Department of Electrical Engineering<br>
                                National Central University<br>
                            </p>
                        </div>
                        
                    </div>

                </div>
            </div>
        </div>    
    </div>

    <!-- ============================================================================ -->

    <div class="introduction" id="intro">

        <div class="contact_div_before">
            <div class="contact_div">
                <div class="contact_p">
                    <h1>Contact</h1>
                    <p>Please join our Google group for direct communication at <a href="rocling23-shared-task@googlegroups.com" target="_blank">rocling23-shared-task@googlegroups.com.</a></p>
                
                </div>
            </div>
        </div>
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Background</h1>
                <p>Named Entity Recognition (NER) is a fundamental task in information extraction that locates the mentions of named entities and classifies them (e.g., person, organization and location) in unstructured texts. The NER task has traditionally been solved as a sequence labeling problem, where entity boundaries and category labels are jointly predicted. Chinese NER is more difficult to process than English NER. Chinese language is logographic and provides no conventional features like capitalization. In addition, due to a lack of delimiters between characters, Chinese NER is correlated with word segmentation, and named entity boundaries are also word boundaries. However, incorrectly segmented entity boundaries will cause error propagation in NER. For example, in a particular context, a disease entity “思覺失調症” (schizophrenia) may be incorrectly segmented into three words: “思覺” (thinking and feeling), “失調” (disorder) and “症” (disease).</p>
                <p>In the digital era, healthcare information-seeking users usually search and browse web content in click-through trails to obtain healthcare-related information before making a doctor’s appointment for diagnosis and treatment. Web texts are valuable sources to provide healthcare information such as health-related news, digital health magazines and medical question/answer forums. Domain-specific healthcare information includes many proper names, mainly as named entities, such as “葡萄糖六磷酸鹽去氫酶” (Glucose-6-Phosphate Dehydrogenase; G6PD), “電腦斷層掃描” (computed tomography; CT), and “靜脈免疫球蛋白注射” (intravenous immunoglobulin; IVIG). In summary, Chinese healthcare NER is an important and essential task in natural language processing to automatically identify healthcare entities such as symptoms, chemicals, diseases, and treatments for machine reading and understanding.</p>
                <p>Following the ROCLING-2022 shared task focused on Chinese healthcare NER, we organize a MultiNER-Health shared task for multi-genre NER in the healthcare domain. In this shared task, we have three genres:</p>
                <div class="part">
                    <p>1.&nbsp;&nbsp;Formal texts (FT): this includes health news and articles written by professional editors or journalists.</p>
                    <br>
                    <p>2.&nbsp;&nbsp;Social media (SM): this contains texts from crowed users in medical question/answer forums.</p>
                    <br>
                    <p>3.&nbsp;&nbsp;Wikipedia articles (WA): this free online encyclopedia includes articles created and edited by volunteers worldwide</p>
                    <br>
                </div>
                <p>Named entities may be used in different word forms in other genres. For example, “後天免疫缺乏症候群” (Acquired Immunodeficiency Syndrome; AIDS) is commonly used as a spoken language form “愛滋病” in the medical forums. On the other hand, “甘油三酯” is a different usage referred to as “三酸甘油酯” (triglyceride; TG) in Wikipedia.</p>
            </div>
<!--             <div class="figure"> -->
                <!-- <p>If you have any questions, </p> -->
                
<!--             </div> -->
        </div>
    </div>
    
    <!-- ============================================================================ -->

    <div class='task' id='task'>
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Task Description</h1>
                <p>A total of 10 entity types are described and some examples are provided in Table I for Chinese healthcare NER. In this task, participants are asked to predict the named entity boundaries and categories for each given sentence. We use the common BIO (Beginning, Inside, and Outside) format for NER tasks. The B-prefix before a tag indicates that the character is the beginning of a named entity and I-prefix before a tag indicates that the character is inside a named entity. An O tag indicates that a token belongs to no named entity. Below are the example sentences.</p>
                <br>
                <style type="text/css">
                  .tg  {border-collapse:collapse;border-spacing:0;}
                  .tg td{border-color:black;border-style:solid;border-width:1px;font-family:Times New Romans, Times New Romans;font-size:20px;
                    overflow:hidden;padding:10px 5px;word-break:normal;}
                  .tg th{border-color:black;border-style:solid;border-width:1px;font-family:Times New Romans, Times New Romans;font-size:20px;
                    font-weight:normal;overflow:hidden;padding:10px 5px;word-break:normal;}
                  .tg .tg-7zrf{background-color:#F3F4F3;border-color:inherit;color:#212121;font-weight:bold;text-align:left;vertical-align:top}
                  .tg .tg-0pky{border-color:inherit;text-align:left;vertical-align:top}
                  </style>
                  <table class="tg"><thead>
                    <caption style ="caption-side: top;text-align: center;font-family:Times New Romans;font-size:20px">Table 1. Named Entity Types</caption>
                    <tr>
                      <th class="tg-0pky"><span style="font-weight:bolder">Entity Type</span></th>
                      <th class="tg-0pky">Description</th>
                      <th class="tg-0pky"><span style="font-weight:bolder;font-style:normal">Examples</span></th>
                    </tr></thead>
                  <tbody>
                    <tr>
                      <td class="tg-0pky">Body (BODY)</td>
                      <td class="tg-0pky">The whole physical structure that forms a person or animal including biological cells, organizations, organs and systems.</td>
                      <td class="tg-0pky">“細胞核” (nucleus), “神經組織” (nerve tissue), “左心房” (left atrium), “脊髓” (spinal cord), “呼吸系統” (respiratory system)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Symptom (SYMP)</td>
                      <td class="tg-0pky">Any feeling of illness or physical or mental change that is caused by a particular disease.</td>
                      <td class="tg-0pky">“流鼻水” (rhinorrhea), “咳嗽” (cough), “貧血” (anemia), “失眠” (insomnia), “心悸” (palpitation), “耳鳴” (tinnitus)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Instrument (INST)</td>
                      <td class="tg-0pky">A tool or other device used for performing a particular medical task such as diagnosis and treatments.</td>
                      <td class="tg-0pky">“血壓計” (blood pressure meter), “達文西手臂” (DaVinci Robots), “體脂肪計” (body fat monitor), “雷射手術刀” (laser scalpel)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Examination (EXAM)</td>
                      <td class="tg-0pky">The act of looking at or checking something carefully in order to discover possible diseases.</td>
                      <td class="tg-0pky">“聽力檢查” (hearing test), “腦電波圖” (electroencephalography; EEG), “核磁共振造影” (magnetic resonance imaging; MRI)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Chemical (CHEM)</td>
                      <td class="tg-0pky">Any basic chemical element typically found in the human body.</td>
                      <td class="tg-0pky">“去氧核糖核酸” (deoxyribonucleic acid; DNA), “糖化血色素” (glycated hemoglobin), “膽固醇” (cholesterol), “尿酸” (uric acid)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Disease (DISE)</td>
                      <td class="tg-0pky">An illness of people or animals caused by infection or a failure of health rather than by an accident.</td>
                      <td class="tg-0pky">“小兒麻痺症” (poliomyelitis; polio), “帕金森氏症” (Parkinson’s disease), “青光眼” (glaucoma), “肺結核” (tuberculosis)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Drug (DRUG)</td>
                      <td class="tg-0pky">Any natural or artificially made chemical used as a medicine.</td>
                      <td class="tg-0pky">“阿斯匹靈” (aspirin), “普拿疼” (acetaminophen), “青黴素” (penicillin), “流感疫苗” (influenza vaccination)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Supplement (SUPP)</td>
                      <td class="tg-0pky">Something added to something else to improve human health.</td>
                      <td class="tg-0pky">“維他命” (vitamin), “膠原蛋白” (collagen), “益生菌” (probiotics), “葡萄糖胺” (glucosamine), “葉黃素” (lutein)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Treatment (TREAT)</td>
                      <td class="tg-0pky">A method of behavior used to treat diseases.</td>
                      <td class="tg-0pky">“藥物治療” (pharmacotherapy), “胃切除術” (gastrectomy), “標靶治療” (targeted therapy), “外科手術” (surgery)</td>
                    </tr>
                    <tr>
                      <td class="tg-0pky">Time (TIME)</td>
                      <td class="tg-0pky">Element of existence measured in minutes, days, years.</td>
                      <td class="tg-0pky">“嬰兒期” (infancy), “幼兒時期” (early childhood), “青春期” (adolescence), “生理期” (on one’s period), “孕期” (pregnancy)</td>
                    </tr>
                  </tbody></table>
                
            </div>  
        </div>
    </div>


    <!-- ============================================================================ -->

    <div class="registration" id="registration">
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Data</h1>
                <br>
                <h2>Training Set: Chinese EmoBank</h2>
                <p><a href="http://nlp.innobic.yzu.edu.tw/resources/ChineseEmoBank.html">http://nlp.innobic.yzu.edu.tw/resources/ChineseEmoBank.html</a></p>
                <br>
                <p>The Chinese EmoBank (Lee et al., 2022) is a dimensional sentiment resource annotated with real-valued scores for both valence and arousal dimensions. The valence represents the degree of positive and negative sentiment, and arousal represents the degree of calm and excitement. Both dimensions range from 1 (highly negative or calm) to 9 (highly positive or excited). The Chinese EmoBank features various levels of text granularity including two lexicons called Chinese valence-arousal words (CVAW, 5,512 single words) and Chinese valence-arousal phrases (CVAP, 2,998 multi-word phrases) and two corpora called Chinese valence-arousal sentences (CVAS, 2,582 single sentences) and Chinese valence-arousal texts (CVAT, 2,969 multi-sentence texts).</p>
                <br>
                <div class="part">
                    <h3 style="color: red;">Notes</h3>
                    <p>The policy of this shared task is an open test. Participating systems are allowed to use other publicly available data for this shared task, but the use of other data should be specified in the final system description paper.</p>
                </div>
                <h2>Test Set</h2>
                <p>at least 1,500 doctors’ self-reflection texts will be provided for system performance evaluation.</p>
            </div>  
        </div>
    </div>
    
    <!-- ============================================================================ -->

    <div class="keynote" id="key_note">
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Evaluation</h1>
                <p>The performance is evaluated by examining the difference between machine-predicted ratings and human-annotated ratings (valence and arousal are treated independently). The evaluation metrics include: <strong>Mean Absolute Error (MAE)</strong> and <strong>Correlation Coefficient (PCC)</strong> , defined as follows</p>
                <p><span>$$ MAE = \frac{1}{n} \sum_{i=1}^{n}|a_{i}-p_{i}| $$</span></p>
                <p><span>$$ PCC = \frac{1}{n-1} \sum_{i=1}^{n}(\frac{a_{i}-\mu_{A}}{\sigma_{A}})(\frac{p_{i}-\mu_{P}}{\sigma_{P}}) $$</span></p>
                <p>where \( a_{i}\in{A} \)  and \( p_{i}\in{P} \)  respectively denote the i-th actual value and predicted value, n is the number of test samples, and \( \mu_{A} \)  and \( \sigma_{A} \) respectively represent the mean value and the standard deviation of A, while \( \mu_{P} \) and \( \sigma_{P} \) respectively represent the mean value and the standard deviation of P. </p>
                <p>The actual and predicted real values range from 1 to 9, so MAE measures the error rate in a range where the lowest value is 0 and the highest value is 8. A lower MAE indicates more accurate prediction performance. The PCC is a value between −1 and 1 that measures the linear correlation between the actual value and the predicated value. A lower MAE and a higher PCC indicate more accurate prediction performance. Each metric for the valence and arousal dimensions is ranked independently. A model’s overall ranking is computed based on the cumulative rank across the four metrics. The lower the cumulative rank, the better the system performance.</p>
            </div>  
        </div>
   
    </div>

    <!-- ============================================================================ -->
    <!-- <div class="introduction" id="ranking">
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Official Ranking</h1>
                
                <p>Notes: Each metric in individual subtask is ranked independently. (*) means the rank for each metric. A system’s overall ranking is computed based on the cumulative rank. The lower the cumulative rank, the better the system performance.</p>
                <br>  
                <style type="text/css">
            .tg  {border-collapse:collapse;border-spacing:0;}
            .tg td{border-color:black;border-style:solid;border-width:1px;font-size:20px;
              overflow:hidden;padding:10px 5px;word-break:normal;}
            .tg th{border-color:black;border-style:solid;border-width:1px;font-size:20px;
              font-weight:normal;overflow:hidden;padding:10px 5px;word-break:normal;}
            .tg .tg-c3ow{border-color:inherit;text-align:center;vertical-align:center;font-size:20px}
            </style>
            <table class="tg"><thead>
              <tr>
                <th class="tg-c3ow" colspan="7"> <strong>Subtask 1: Intensity Prediction </strong></th>
              </tr></thead>
            <tbody>
              <tr>
                <td class="tg-c3ow" rowspan="2">Team</td>
                <td class="tg-c3ow" rowspan="2">Sub#</td>
                <td class="tg-c3ow" colspan="4">Evaluation Metrics</td>
                <td class="tg-c3ow" rowspan="2">Overall Rank</td>
              </tr>
              <tr>
                <td class="tg-c3ow">V-MAE</td>
                <td class="tg-c3ow">V-PCC</td>
                <td class="tg-c3ow">A-MAE</td>
                <td class="tg-c3ow">A-PCC</td>
              </tr>
              <tr>
                <td class="tg-c3ow">HITSZ-HLT</td>
                <td class="tg-c3ow">63885</td>
                <td class="tg-c3ow"><strong>0.279</strong> (1)</td>
                <td class="tg-c3ow"><strong>0.933</strong> (1)</td>
                <td class="tg-c3ow"><strong>0.309</strong> (1)</td>
                <td class="tg-c3ow"><strong>0.777</strong> (1)</td>
                <td class="tg-c3ow">1</td>
              </tr>
              <tr>
                <td class="tg-c3ow">CCIIPLab</td>
                <td class="tg-c3ow">63706</td>
                <td class="tg-c3ow">0.294 (2)</td>
                <td class="tg-c3ow">0.916 (3)</td>
                <td class="tg-c3ow"><strong>0.309</strong> (1)</td>
                <td class="tg-c3ow">0.766 (3)</td>
                <td class="tg-c3ow">2</td>
              </tr>
              <tr>
                <td class="tg-c3ow">YNU-HPCC</td>
                <td class="tg-c3ow">63756</td>
                <td class="tg-c3ow">0.294 (2)</td>
                <td class="tg-c3ow">0.917 (2)</td>
                <td class="tg-c3ow">0.318 (3)</td>
                <td class="tg-c3ow">0.771 (2)</td>
                <td class="tg-c3ow">2</td>
              </tr>
              <tr>
                <td class="tg-c3ow">DS-Group</td>
                <td class="tg-c3ow">62014</td>
                <td class="tg-c3ow">0.460 (4)</td>
                <td class="tg-c3ow">0.858 (5)</td>
                <td class="tg-c3ow">0.501 (4)</td>
                <td class="tg-c3ow">0.490 (4)</td>
                <td class="tg-c3ow">4</td>
              </tr>
              <tr>
                <td class="tg-c3ow">yangnan</td>
                <td class="tg-c3ow">61884</td>
                <td class="tg-c3ow">1.032 (5)</td>
                <td class="tg-c3ow">0.877 (4)</td>
                <td class="tg-c3ow">1.095 (5)</td>
                <td class="tg-c3ow">0.097 (5)</td>
                <td class="tg-c3ow">5</td>
              </tr>
            </tbody></table>

            <br>

            <style type="text/css">
            .tg  {border-collapse:collapse;border-spacing:0;}
            .tg td{border-color:black;border-style:solid;border-width:1px;font-size:20px;
              overflow:hidden;padding:10px 5px;word-break:normal;}
            .tg th{border-color:black;border-style:solid;border-width:1px;font-size:20px;
              font-weight:normal;overflow:hidden;padding:10px 5px;word-break:normal;}
            .tg .tg-baqh{text-align:center;vertical-align:center;font-size:20px}
            .tg .tg-c3ow{border-color:inherit;text-align:center;vertical-align:center;font-size:20px}
                table {
            margin: auto;
            border-collapse: collapse;
            width: 80%; /* 根据需要调整宽度 */
        }
            </style>
            <table class="tg"><thead>
              <tr>
                <th class="tg-c3ow" colspan="6"> <strong> Subtask 2: Triplet Extraction </strong></th>
              </tr></thead>
            <tbody>
              <tr>
                <td class="tg-c3ow" rowspan="2">Team</td>
                <td class="tg-c3ow" rowspan="2">Sub#</td>
                <td class="tg-c3ow" colspan="3">Evaluation Metrics</td>
                <td class="tg-c3ow" rowspan="2">Overall Rank</td>
              </tr>
              <tr>
                <td class="tg-c3ow">V-Tri-F1</td>
                <td class="tg-c3ow">A-Tri-F1</td>
                <td class="tg-c3ow">VA-Tri-F1</td>
              </tr>
              <tr>
                <td class="tg-c3ow">HITSZ-HLT</td>
                <td class="tg-c3ow">63885</td>
                <td class="tg-c3ow"><strong>0.589</strong> (1)</td>
                <td class="tg-c3ow"><strong>0.545</strong> (1)</td>
                <td class="tg-c3ow"><strong>0.433</strong> (1)</td>
                <td class="tg-c3ow">1</td>
              </tr>
              <tr>
                <td class="tg-c3ow">CCIIPLab</td>
                <td class="tg-c3ow">63824</td>
                <td class="tg-c3ow">0.573 (2)</td>
                <td class="tg-c3ow">0.522 (2)</td>
                <td class="tg-c3ow">0.403 (2)</td>
                <td class="tg-c3ow">2</td>
              </tr>
              <tr>
                <td class="tg-c3ow">ZZU-NLP</td>
                <td class="tg-c3ow">63737</td>
                <td class="tg-c3ow">0.542 (3)</td>
                <td class="tg-c3ow">0.507 (3)</td>
                <td class="tg-c3ow">0.389 (3)</td>
                <td class="tg-c3ow">3</td>
              </tr>
              <tr>
                <td class="tg-c3ow">BIT-NLP</td>
                <td class="tg-c3ow">63766</td>
                <td class="tg-c3ow">0.490 (4)</td>
                <td class="tg-c3ow">0.450 (4)</td>
                <td class="tg-c3ow">0.342 (4)</td>
                <td class="tg-c3ow">4</td>
              </tr>
              <tr>
                <td class="tg-c3ow">SUDA-NLP</td>
                <td class="tg-c3ow">63827</td>
                <td class="tg-c3ow">0.475 (5)</td>
                <td class="tg-c3ow">0.448 (5)</td>
                <td class="tg-c3ow">0.326 (5)</td>
                <td class="tg-c3ow">5</td>
              </tr>
              <tr>
                <td class="tg-baqh">TMAK-Plus</td>
                <td class="tg-baqh">63972</td>
                <td class="tg-baqh">0.269 (6)</td>
                <td class="tg-baqh">0.307 (6)</td>
                <td class="tg-baqh">0.157 (6)</td>
                <td class="tg-baqh">6</td>
              </tr>
            </tbody></table>
            
            <br>

            <style type="text/css">
.tg  {border-collapse:collapse;border-spacing:0;}
.tg td{border-color:black;border-style:solid;border-width:1px;font-size:20px;
  overflow:hidden;padding:10px 5px;word-break:normal;}
.tg th{border-color:black;border-style:solid;border-width:1px;font-size:20px;
  font-weight:normal;overflow:hidden;padding:10px 5px;word-break:normal;}
.tg .tg-baqh{text-align:center;vertical-align:center;font-size:20px}
.tg .tg-c3ow{border-color:inherit;text-align:center;vertical-align:center;font-size:20px}
</style>
<table class="tg"><thead>
  <tr>
    <th class="tg-c3ow" colspan="6"> <strong>Subtask 3: Quadruple Extraction</strong></th>
  </tr></thead>
<tbody>
  <tr>
    <td class="tg-c3ow" rowspan="2">Team</td>
    <td class="tg-c3ow" rowspan="2">Sub#</td>
    <td class="tg-c3ow" colspan="3">Evaluation Metrics</td>
    <td class="tg-c3ow" rowspan="2">Overall Rank</td>
  </tr>
  <tr>
    <td class="tg-c3ow">V-Quad-F1</td>
    <td class="tg-c3ow">A-Quad-F1</td>
    <td class="tg-c3ow">VA-Quad-F1</td>
  </tr>
  <tr>
    <td class="tg-c3ow">HITSZ-HLT</td>
    <td class="tg-c3ow">63885</td>
    <td class="tg-c3ow"><strong>0.567</strong> (1)</td>
    <td class="tg-c3ow"><strong>0.526</strong> (1)</td>
    <td class="tg-c3ow"><strong>0.417</strong> (1)</td>
    <td class="tg-c3ow">1</td>
  </tr>
  <tr>
    <td class="tg-c3ow">CCIIPLab</td>
    <td class="tg-c3ow">63832</td>
    <td class="tg-c3ow">0.555 (2)</td>
    <td class="tg-c3ow">0.507 (2)</td>
    <td class="tg-c3ow">0.389 (2)</td>
    <td class="tg-c3ow">2</td>
  </tr>
  <tr>
    <td class="tg-c3ow">ZZU-NLP</td>
    <td class="tg-c3ow">61868</td>
    <td class="tg-c3ow">0.522 (3)</td>
    <td class="tg-c3ow">0.489 (3)</td>
    <td class="tg-c3ow">0.376 (3)</td>
    <td class="tg-c3ow">3</td>
  </tr>
  <tr>
    <td class="tg-c3ow">SUDA-NLP</td>
    <td class="tg-c3ow">63622</td>
    <td class="tg-c3ow">0.487 (4)</td>
    <td class="tg-c3ow">0.444 (4)</td>
    <td class="tg-c3ow">0.336 (4)</td>
    <td class="tg-c3ow">4</td>
  </tr>
  <tr>
    <td class="tg-c3ow">JN-NLP</td>
    <td class="tg-c3ow">63572</td>
    <td class="tg-c3ow">0.482 (5)</td>
    <td class="tg-c3ow">0.439 (5)</td>
    <td class="tg-c3ow">0.331 (5)</td>
    <td class="tg-c3ow">5</td>
  </tr>
  <tr>
    <td class="tg-baqh">BIT-NLP</td>
    <td class="tg-baqh">63766</td>
    <td class="tg-baqh">0.470 (6)</td>
    <td class="tg-baqh">0.434 (7)</td>
    <td class="tg-baqh">0.329 (6)</td>
    <td class="tg-baqh">6</td>
  </tr>
  <tr>
    <td class="tg-baqh">USTC-IAT</td>
    <td class="tg-baqh">63907</td>
    <td class="tg-baqh">0.438 (7)</td>
    <td class="tg-baqh">0.437 (6)</td>
    <td class="tg-baqh">0.312 (7)</td>
    <td class="tg-baqh">7</td>
  </tr>
</tbody></table>
            </div>
        </div>
    </div> -->

    <!-- ============================================================================ -->

    <!-- <div class='Tutorials' id='task_paper'>
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Task Paper</h1>
                <p>If you have built a successful system and completed a submission on the leaderboard, we gladly invite you to submit a shared task paper to the SIGHAN 2024 workshop. If you would like to publish a paper, please carefully follow these instructions:</p>
                <div class="part">
                    <p>1.&nbsp;&nbsp;Write your paper using the <a href= https://github.com/acl-org/acl-style-files target="_blank">ACL 2024 template</a>.</p>
                    <br>
                    <p>2.&nbsp;&nbsp;Papers must be written in English.</p>
                    <br>
                    <p>3.&nbsp;&nbsp;Paper titles should adopt the format: <strong>“TEAM_NAME at SIGHAN-2024 dimABSA Task:”</strong> followed by a descriptive title of the proposed approach.</p>
                    <br>
                    <p>4.&nbsp;&nbsp;Submissions are not anonymous for review, so author names and affiliations could be included in the paper.</p>
                    <br>
                    <p>5.&nbsp;&nbsp;The page limitation is four pages (excluding references) for a single subtask; and the length limit is eight pages (excluding references) for multiple subtasks.</p>
                    <br>
                    <p>6.&nbsp;&nbsp;Please cite the following overview paper (just as we will cite your task paper).</p>
                    <br>
                    <p>Lung-Hao Lee, Liang-Chih Yu, Suge Wang, and Jian Liao. 2024. Overview of the SIGHAN 2024 shared task for Chinese dimensional aspect-based sentiment analysis. In <em>Proceedings of the 10th SIGHAN Workshop on Chinese Language Processing</em>. Association for Computational Linguistics.</p>
                    <br>
                    <p>7.&nbsp;&nbsp;Submission Deadline: <strong>17th June, 2024</strong> (anywhere on Earth)</p>
                    <br>
                    <p>8.&nbsp;&nbsp;Submission Site: <a href= https://openreview.net/group?id=aclweb.org/ACL/2024/Workshop/SIGHAN-10 target="_blank">OpenReview</a></p>
                    <br>
                    <p>9.&nbsp;&nbsp;<a href= https://docs.google.com/forms/d/e/1FAIpQLSeaJrvX1i3OO5z6-foEZB347jzNOIl30DoQKWjActQuGwZqNg/viewform target="_blank">Reviewer Nomination</a>: Similar to other shared tasks (e.g. SemEval), we ask at least one author per paper also acts as a reviewer. Please nominate the reviewer by the submssion deadline. If you do not nominate a reviewer, the first author or corresponding author will be automatically selected.</p>
                    <br>
                    <p>10.&nbsp;&nbsp;Each accepted task paper will be included in the SIGHAN-2024 proceedings. At least one author must register to present their developed system at the SIGHAN-2024 Workshop (16th August, collocated with ACL 2024, in Bangkok, Thailand).</p>
                </div>
                <p>The evaluation committee will select the Best Evaluation Paper Award and recommend two evaluation papers for publication in the <a href=https://www.mdpi.com/journal/electronics/special_issues/Affective_Computing target="_blank">Special Issue on New Advances in Affective Computing， Electronics (IF 2.9)</a>.</p>
            </div>  
        </div>
    </div> -->
    
    <!-- ============================================================================ -->

    <div class="special_session" id='special'>
        
        <div class="introduce_div_before">
            <div class="introduce_div">
                <h1>Important Dates</h1>
                <div class="part">
                    <!-- <h2>Important Dates</h2> -->
                    <!-- <h2>V.&emsp;Important Dates</h2> -->
                        <!-- <p>Registration:
                            <a href="https://docs.google.com/forms/d/e/1FAIpQLSe74D0A_sWAOKH_xtz9_uF7ws9G-cdF2gYiEm5YwONQOcctrA/viewform?vc=0&c=0&w=1&flr=0" target="_blank" title="uninstructed">
                                Click here
                            </a>
                        </p> -->
                    
                    <div class="list">
                        <ul>
                            <li>Release of training data: <strong>April 15, 2023</strong></li>
                            <li>Shared task registration due: <strong>July 25, 2023</strong></li>
                            <li>Release of test data: <strong>August 1, 2023</strong></li>
                            <li>Testing results submission due: <strong>August 3, 2023</strong></li>
                            <li>Release of evaluation results: <strong>August 7, 2023</strong></li>
                            <li>System description paper due: <strong>August 25, 2023</strong></li>
                            <li>Notification of Acceptance: <strong>September 8, 2023</strong></li>
                            <li>Camera-ready deadline: <strong>September 15, 2023/strong></li>
                            <li>Main conference: <strong>October 20-21, 2023</strong></li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- ============================================================================ -->
    
    <div class="sharetask" id="ref">
        
        <div class="part">
            <h1>References</h1>
            <!-- <h2>References</h2> -->
            <div class="list">
                
                <ul>
                    <li>Lung-Hao Lee, and Yi Lu (2021). Multiple Embeddings Enhanced Multi-Graph Neural Networks for Chinese Healthcare Named Entity Recognition. IEEE Journal of Biomedical and Health Informatics (IEEE JBHI), 25(7): 2801- 2810.</li>
                    <li>Lung-Hao Lee, Chao-Yi Chen, Liang-Chih Yu, and Yuen-Hsien Tseng (2022). Overview of the ROCLING 2022 Shared Task for Chinese Healthcare Named Entity Recognition. In Proceedings of the 34th Conference on Computational Linguistics and Speech Processing (ROCLING'22), pp. 363-368.</li>
                </ul>
            </div>
        </div>
    </div>

    <!-- ============================================================================ -->
    <div class="footer">
        &copy;SIGHAN 2024 Shared Task || Updated: February 23, 2024
    </div>
    
    <!-- 匯入main javascript -->
    <script src="main.js"></script>

</body>

</html>
